Panagora Asset Management Inc. raised its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 117.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 326,585 shares of the business services provider’s stock after acquiring an additional 176,210 shares during the period. Panagora Asset Management Inc. owned approximately 0.19% of Genpact worth $14,373,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Cetera Investment Advisers grew its holdings in Genpact by 288.3% during the first quarter. Cetera Investment Advisers now owns 51,526 shares of the business services provider’s stock worth $2,596,000 after acquiring an additional 38,257 shares during the period. LPL Financial LLC boosted its position in Genpact by 202.8% in the 1st quarter. LPL Financial LLC now owns 109,819 shares of the business services provider’s stock worth $5,533,000 after purchasing an additional 73,551 shares in the last quarter. Natixis Advisors LLC grew its stake in shares of Genpact by 3.8% during the 1st quarter. Natixis Advisors LLC now owns 125,974 shares of the business services provider’s stock worth $6,347,000 after purchasing an additional 4,641 shares during the period. Jefferies Financial Group Inc. acquired a new stake in shares of Genpact during the 1st quarter worth approximately $530,000. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Genpact by 9.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 15,843 shares of the business services provider’s stock valued at $798,000 after purchasing an additional 1,375 shares in the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Trading Down 0.2%
Shares of G stock opened at $44.09 on Wednesday. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 0.33. Genpact Limited has a twelve month low of $37.49 and a twelve month high of $56.76. The company’s 50-day moving average price is $41.57 and its 200-day moving average price is $43.01. The stock has a market cap of $7.60 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 1.42 and a beta of 0.76.
Genpact Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. Genpact’s dividend payout ratio is 21.94%.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on G. Citigroup upgraded shares of Genpact to a “hold” rating in a research report on Thursday, October 23rd. JPMorgan Chase & Co. cut their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research note on Wednesday, August 20th. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a report on Saturday, November 15th. Weiss Ratings restated a “hold (c)” rating on shares of Genpact in a research report on Wednesday, October 8th. Finally, Needham & Company LLC upped their target price on Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Genpact presently has an average rating of “Hold” and an average price target of $51.13.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 55,000 shares of the business’s stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Tamara Franklin sold 2,750 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the transaction, the director owned 22,236 shares of the company’s stock, valued at $1,015,073.40. This trade represents a 11.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 161,183 shares of company stock worth $6,970,760 over the last ninety days. Company insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- What is the NASDAQ Stock Exchange?
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- What Are Dividend Challengers?
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- What Are Some of the Best Large-Cap Stocks to Buy?
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
